Virtus LifeSci Biotech Clinical Trials ETF
19 hedge funds and large institutions have $18.2M invested in Virtus LifeSci Biotech Clinical Trials ETF in 2020 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 2 closing their positions.
Holders
19
Holders Change
+4
Holders Change %
+26.67%
% of All Funds
0.39%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
6
Increased
7
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
FEM
1
Fulcrum Equity Management
Plano,
Texas
|
$2.09M |
2 |
2
LPL Financial
San Diego,
California
|
$1.83M |
3 |
3
Morgan Stanley
New York
|
$1.36M |
4 |
NCM
4
Niemann Capital Management
Stateline,
Nevada
|
$2.06M |
5 |
5
Osaic Holdings
Scottsdale,
Arizona
|
$663K |